This KFF Health Tracking Poll finds that the cost of health care is a more prominent focus for Make America Healthy Again (MAHA) voters than issues like food and vaccine policy. Four in ten MAHA voters (42%) choose lowering health costs as the most important health priority, outranking other MAHA priorities.
Chemical food additive and pesticide concerns associated with the Make America Health Again (MAHA) movement are shared broadly across the public. But when it comes to voters, health care costs are a higher priority and bigger motivator, even among MAHA supporters, a new KFF Health Tracking Poll finds.
Let’s say you’re the CEO of a health plan. A new drug just received approval to treat patients with lung cancer. The drug’s clinical trial examined how well the the drug worked on third line (3L) patients and patients with good funcional ability (e.g., performance status ECOG score of 0 or 1). FDA approved the…
Multiple federal agencies have signed a letter supporting prescribing practices
Disagreements between providers and payers have been moving into the courtroom over the past few weeks. The California Hospital Association sued Anthem over one of its out-of-network policies, Broward Health sued Florida Blue over alleged underpayment, and Jefferson Health sued Aetna over a Medicare Advantage hospital stay rule. The post Provider-Payer Tensions Brew in Courtrooms:…
Only 2 percent of UnitedHealthcare services currently require prior approval
Parsley Health is now in-network with major insurers nationwide, including UnitedHealthcare, Aetna and Cigna. The post Parsley Health Wins Greater Insurance Coverage for its Functional Medicine appeared first on MedCity News.
Joanne Fulmer, St. Luke’s director of operations, says Auxira embeds a dedicated virtual Advanced Practice Provider directly into cardiology care teams
Madrigal Pharmaceuticals has licensed rights to an Arrowhead Pharmaceuticals small-interfering RNA therapy designed to address a particular genetic mutation associated with the fatty liver disease MASH. It’s Madrigal’s fourth business development deal of the past year and the company’s second one involving siRNA therapies. The post Madrigal Pharma Adds Another Genetic Medicine to Its Drug…
If AI is going to be used in MSK care — or any area of healthcare — it needs clear, non-negotiable rules around it. The post How I Learned To Trust AI as a Physical Therapist appeared first on MedCity News.